Classical nodular sclerosis Hodgkin lymphoma presenting with atypical cardiac involvement
Abstract
Keywords
Full Text:
PDFReferences
Amano J, Nakayama J, Yoshimura Y, Ikeda U. Clinical classification of cardiovascular tumors and tumor-likelesions, and its incidences. Gen Thorac Cardiovasc Surg 2013; 61:435–447.
Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol 2005; 6:219–228.
Maraj S, Pressman GS, Figueredo VM et al. Review Primary Cardiac Tumors. Int J Cardiol 2009; 133:152–156.
Miguel CE, Bestetti RB. Primary cardiac lymphoma. Int J Cardiol 2011; 149:358–363.
Amirimoghaddam Z, Khoddami M, Nayeri ND, Molaee S. Hodgkin’s lymphoma presenting with heart failure: a case report. J Med Case Rep 2010; 4:14.
Rolla G, Calligaris-Cappio F, Burke AP. Cardiac lymphomas. In Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds.) World Health Organization. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004:282–286.
Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer 2011; 17(3):581-589.
Habertheuer A, Ehrlich M, Wiedemann D, Mora B, Rath C, Kocher A. A rare case of primary cardiac B cell lymphoma. J Cardiothorac Surg 2014; 9:14.
Leja MJ, Shah DJ, Reardon MJ. Primary Cardiac Tumors. Tex Heart Inst J 2011; 38(3):261–262.
Expert Group on Biomarkers. Biomarkers in Cardiology – Part 1 – In Heart Failure and Specific Cardiomyopathies. Arq Bras Cardiol 2014; 103(6):451–459.
Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7(11):1630-1636.
Engert A, Eichenauer DA, Dreyling M; ESMO Guidelines Working Group. Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2010; 21(5):168-171.
Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009; 523-531.
National Comprehensive Cancer Network. Hodgkin’s Lymphoma in NCCN Clinical Practice Guidelines in Oncology. V.2.2015.
Holladay AO, Siegel RJ, Schwartz DA. Cardiac malignantlymphoma in acquired immune deficiency syndrome. Cancer 1992; 70:2203-2207.
Montalbetti L, Della Volpe A, Airaghi ML, Landoni C, Brambilla-Pisoni G, Pozzi S. Primary cardiac lymphoma.A case report and review. Minerva Cardioangiol 1999; 47:175-182.
Timóteo AT, Gouveia R, Gonçalves PA et al. Lymphoma with Clinical Presentation of a Primary Pericardial Tumor. Rev Port Cardiol 2003; 22(11):1385-1391.
Eich HT, Diehl V, Görgen H, et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J ClinOncol 2010; 28(27):4199-4206.
Volkova M, Russell R. Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment. Curr Cardiol Rev 2011; 7:214-220.
Zuppinger C, Timolati F, Suter TM. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovasc Toxicol 2007; 7:61-66.
Hochster HS. Clinical pharmacology of dexrazoxane. Semin Oncol 1998; 25(10):37-42.
Cardinale D, Sandri MT, Martinoni A. Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. Ann Oncol 2002; 13(5):710-715.
DOI: http://dx.doi.org/10.22551/2016.10.0301.10064
Copyright (c) 2016 Archive of Clinical Cases
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975